These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10482415)

  • 1. Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine: preparation of antigen-adsorbed microsphere and in vitro release.
    Mi FL; Shyu SS; Chen CT; Schoung JY
    Biomaterials; 1999 Sep; 20(17):1603-12. PubMed ID: 10482415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-sensitive polyelectrolyte complex gel microspheres composed of chitosan/sodium tripolyphosphate/dextran sulfate: swelling kinetics and drug delivery properties.
    Lin WC; Yu DG; Yang MC
    Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):143-51. PubMed ID: 16054345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on immune efficacy of Newcastle disease chitosan microsphere vaccine].
    Zhai RL; Xu HY; Wang YL; Qin ZM; Jiang SJ
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):692-6. PubMed ID: 17944374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide.
    Ganza-González A; Anguiano-Igea S; Otero-Espinar FJ; Blanco Méndez J
    Eur J Pharm Biopharm; 1999 Sep; 48(2):149-55. PubMed ID: 10469933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of uniform-sized chitosan microspheres containing insulin by membrane emulsification and a two-step solidification process.
    Wang LY; Gu YH; Zhou QZ; Ma GH; Wan YH; Su ZG
    Colloids Surf B Biointerfaces; 2006 Jul; 50(2):126-35. PubMed ID: 16787743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of chitosan microparticles intended for controlled drug delivery.
    Ko JA; Park HJ; Hwang SJ; Park JB; Lee JS
    Int J Pharm; 2002 Dec; 249(1-2):165-74. PubMed ID: 12433445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different molecular weight chitosan microspheres: influence on drug loading and drug release.
    Genta I; Perugini P; Pavanetto F
    Drug Dev Ind Pharm; 1998 Aug; 24(8):779-84. PubMed ID: 9876526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan microspheres as immobilized dye affinity support for catalase adsorption.
    Shentu J; Wu J; Song W; Jia Z
    Int J Biol Macromol; 2005 Oct; 37(1-2):42-6. PubMed ID: 16183111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitin/PLGA blend microspheres as a biodegradable drug-delivery system: phase-separation, degradation and release behavior.
    Mi FL; Lin YM; Wu YB; Shyu SS; Tsai YH
    Biomaterials; 2002 Aug; 23(15):3257-67. PubMed ID: 12102197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan based hydrogel microspheres as drug carriers.
    Vodná L; Bubeníková S; Lacík I; Chorvát D; Bakos D
    Macromol Biosci; 2007 May; 7(5):629-34. PubMed ID: 17477445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-2'-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine.
    Dai C; Kang H; Yang W; Sun J; Liu C; Cheng G; Rong G; Wang X; Wang X; Jin Z; Zhao K
    Carbohydr Polym; 2015 Oct; 130():280-9. PubMed ID: 26076628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication of a pure porous chitosan bead matrix: influences of phase separation on the microstructure.
    Ro IJ; Kwon IC
    J Biomater Sci Polym Ed; 2002; 13(7):769-82. PubMed ID: 12296443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microspheres of alginate-chitosan containing isoniazid.
    Lucinda-Silva RM; Evangelista RC
    J Microencapsul; 2003; 20(2):145-52. PubMed ID: 12554370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of formulation variables on cis-platin loaded chitosan microsphere properties.
    Akbuğa J; Bergişadi N
    J Microencapsul; 1999; 16(6):697-703. PubMed ID: 10575622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure.
    Shu XZ; Zhu KJ
    Int J Pharm; 2002 Feb; 233(1-2):217-25. PubMed ID: 11897426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery.
    Shu XZ; Zhu KJ
    Int J Pharm; 2000 May; 201(1):51-8. PubMed ID: 10867264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics.
    Akbuğa J; Bergişadi N
    J Microencapsul; 1996; 13(2):161-8. PubMed ID: 8999121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan microparticle preparation for controlled drug release by response surface methodology.
    Ko JA; Park HJ; Park YS; Hwang SJ; Park JB
    J Microencapsul; 2003; 20(6):791-7. PubMed ID: 14594667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers].
    Lin X; Tang X; Xu YH; Zhang Y; Zhang Y; He HB
    Yao Xue Xue Bao; 2015 Jun; 50(6):775-82. PubMed ID: 26521452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.